Functional characterization of a bioengineered liver after heterotopic implantation in pigs
QH301-705.5
Sus scrofa
Human Umbilical Vein Endothelial Cells / transplantation
610
Hepatocytes / transplantation
Sus scrofa / surgery
Article
03 medical and health sciences
617
Human Umbilical Vein Endothelial Cells
Animals
Humans
Tissue Engineering / methods*
Biology (General)
0303 health sciences
Tissue Engineering
Animal
Liver Transplantation / methods*
Acute / surgery
Liver Failure, Acute
Liver / surgery
Liver Transplantation
Perfusion
Disease Models, Animal
Liver
Disease Models
Hepatocytes
Liver Failure
DOI:
10.1038/s42003-021-02665-2
Publication Date:
2021-10-07T10:25:59Z
AUTHORS (14)
ABSTRACT
AbstractOrgan bioengineering offers a promising solution to the persistent shortage of donor organs. However, the progression of this technology toward clinical use has been hindered by the challenges of reconstituting a functional vascular network, directing the engraftment of specific functional cell types, and defining appropriate culture conditions to concurrently support the health and phenotypic stability of diverse cell lineages. We previously demonstrated the ability to functionally reendothelialize the vasculature of a clinically scaled decellularized liver scaffold with human umbilical vein endothelial cells (HUVECs) and to sustain continuous perfusion in a large animal recovery model. We now report a method for seeding and engrafting primary porcine hepatocytes into a bioengineered liver (BEL) scaffold previously reendothelialized with HUVECs. The resulting BELs were competent for albumin production, ammonia detoxification and urea synthesis, indicating the presence of a functional hepatocyte compartment. BELs additionally slowed ammonia accumulation during in vivo perfusion in a porcine model of surgically induced acute liver failure. Following explant of the graft, BEL parenchyma showed maintenance of canonical endothelial and hepatocyte markers. Taken together, these results support the feasibility of engineering a clinically scaled functional BEL and establish a platform for optimizing the seeding and engraftment of additional liver specific cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....